Institutional investors purchased a net $260.1 thousand shares of NNVC during the quarter ended December 2016. This may signal that the smart money is gaining interest in this company as the 5.57% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
IFP ADVISORS, INC. Bought 1.8 Thousand shares of NanoViricides Inc
CREATIVE PLANNING, INC. Sold 8.6 Thousand shares of NanoViricides Inc